[
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-1",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#definitiongeneral405619",
    "clean_content": "Definition / general\n\n* Indeterminate cell histiocytosis is an extremely rare neoplastic proliferation of cells of dendritic / histiocytic lineage that share immunophenotypic features of Langerhans cells but lack Birbeck granules and langerin expression"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-2",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#essentialfeatures405620",
    "clean_content": "Essential features\n\n* Skin involvement can be solitary or multifocal* Usually restricted to skin, with rare organ or lymph node involvement* Indeterminate cells are histopathologically and antigenically similar to Langerhans cells but lack Birbeck granules and langerin (CD207) expression* Clinical course varies: spontaneous regression, stable disease, rapid progression or recurrence"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-3",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#terminology405621",
    "clean_content": "Terminology\n\n* Indeterminate cell histiocytosis* Indeterminate cell tumor* Indeterminate dendritic cell tumor"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-4",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#icdcoding405622",
    "clean_content": "ICD coding\n\n* ICD-10: [D76.3](https://www.icd10data.com/ICD10CM/Codes/D50-D89/D70-D77/D76-/D76.3) - other histiocytosis syndromes"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-5",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#epidemiology405623",
    "clean_content": "Epidemiology\n\n* Rare neoplasm, with 85 cases reported between 1985 - 2016 ([Am J Dermatopathol 2018;40:736](29877893))* Reported in all age groups, with a median age of 45* Near equal M:F"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-6",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#sites405624",
    "clean_content": "Sites\n\n* Cutaneous involvement (88%) is most common ([Am J Dermatopathol 2018;40:736](29877893))* Lymph node (9%) and spleen (2.3%) involvement less common ([Am J Dermatopathol 2018;40:736](29877893))"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-7",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#etiology405626",
    "clean_content": "Etiology\n\n* Etiology remains uncertain* Multiple hypotheses on the relationship between indeterminate cells and Langerhans cells, including:\n    + Indeterminate cells are Langerhans cells that have lost their Birbeck granules+ Indeterminate cells are immature Langerhans cells* A subset of cases express dendritic cell marker ZBTB46, raising the possibility that a subset of cases arise directly from bone marrow progenitors as opposed to embryonic precursors that locally renew in the skin ([Mod Pathol 2018;31:1479](29743654))* Association between other hematologic neoplasms has been reported (including B cell lymphoma, T cell lymphoma, acute myeloid leukemia and chronic myelomonocytic leukemia) ([Am J Surg Pathol 2008;32:1868](18813122), [J Cutan Pathol 2017;44:958](28880462), [Am J Dermatopathol 2019;41:461](30024412), [Dermatol Res Pract 2010;2010:569345](20672000))* Indeterminate cell histiocytosis can share clonal abnormality of associated lymphoma or leukemia ([Am J Surg Pathol 2008;32:1868](18813122))"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-8",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#clinicalfeatures405628",
    "clean_content": "Clinical features\n\n* Reported in all age groups, with a median age of 45* Near equal M:F patients* Single cutaneous papulonodule or multiple lesions (few to innumerable)* Can have plaques and tumors with leonine facies ([J Cutan Pathol 2016;43:158](26272726))* Usually restricted to skin with rare organ or lymph node involvement* Clinical course varies: spontaneous regression, stable disease, rapid progression or recurrence* Reference: [Am J Dermatopathol 2018;40:736](29877893)"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-9",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#diagnosis405629",
    "clean_content": "Diagnosis\n\n* Skin biopsy for localized lesions* Systemic workup to exclude deep involvement* CT scans and bone marrow biopsy"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-10",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#laboratory405630",
    "clean_content": "Laboratory\n\n* Can have elevated lactate dehydrogenase, erythrocyte sedimentation rate and C reactive protein ([Serbian J Dermatology Venereol 2018;10:18](https://doi.org/10.2478/sjdv-2018-0004))"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-11",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#radiologydescription405631",
    "clean_content": "Radiology description\n\n* True cutaneous indeterminate cell histiocytosis typically lacks evidence of deep organ involvement on imaging"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-12",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#prognosticfactors405633",
    "clean_content": "Prognostic factors\n\n* Cases restricted to the skin typically behave indolently* Involvement of deep or visceral tissues or bone marrow may portend worse prognosis"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-13",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#casereports405634",
    "clean_content": "Case reports\n\n* 6 year old girl with polypoid and verrucoid lesions of the vulva ([Am J Dermatopathol 2018;40:736](29877893))* 13 year old girl with pityriasis rosea type rash ([Acta Derm Venereol 2002;82:288](12361135))* 28 year old man presented after a mosquito bite ([Medicine (Baltimore) 2015;94:e1443](26313805))* 48 year old woman with a later diagnosis of mycosis fungoides ([Am J Dermatopathol 2019;41:461](30024412))* 55 year old woman with a history of burning and confluent erythematous papules on the face and arms ([Cureus 2021;13:e12850](33628700))* 55 year old woman presented with leonine facies ([J Cutan Pathol 2016;43:158](26272726))* 55 year old man with complete response to ultraviolet phototherapy ([J Cutan Pathol 2017;44:958](28880462))* 61 year old man with recurrence after excision ([J Pathol Transl Med 2018;52:243](29621879))* 72 year old man with chronic myelomonocytic leukemia ([J Cutan Pathol 2017;44:958](28880462))* 74 year old woman with a prior history of follicular lymphoma demonstrating t(14;18) translocation ([Am J Surg Pathol 2008;32:1868](18813122))* 90 year old man with aggressive case mimicking angiosarcoma ([Ann Dermatol 2017;29:614](28966519))"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-14",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#treatment405635",
    "clean_content": "Treatment\n\n* Surgical excision for isolated lesions* Psoralen and ultraviolet A therapy (PUVA) ([J Cutan Pathol 2017;44:958](28880462), [Autops Case Rep 2016;6:33](27547741), [Kaohsiung J Med Sci 2004;20:24](15481563))* Chemotherapy can be considered for more aggressive disease or those cases associated with concurrent myeloid or lymphoid neoplasm"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-15",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#clinicalimages405636",
    "clean_content": "Clinical images\n\nImages hosted on other servers:  \n\n[![Erythematous papules on face and neck](https://www.pathologyoutlines.com/thumb/lymphnodesindeterminatecelltumorspmc02.jpg)](https://pubmed.ncbi.nlm.nih.gov/33628700/#&gid=article-figures&pid=figure-1-uid-0)\n\nErythematous papules on face and neck\n\n[![](https://www.pathologyoutlines.com/thumb/lymphnodesindeterminatecelltumorspmc03.jpg)](https://pubmed.ncbi.nlm.nih.gov/26265687/#&gid=article-figures&pid=fig-1-uid-0)\n\nIll defined, erythematous subcutaneous nodule"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-16",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#microscopichistologicdescription405641",
    "clean_content": "Microscopic (histologic) description\n\n* Dermal infiltration by pale eosinophilic histiocytic cells with reniform nuclei* Background reactive lymphocytes* Scant to absent eosinophils* Can have multinucleated cells* Spindled morphology is less common* References: [Am J Dermatopathol 2018;40:736](29877893), [Blood 2015;126:2344](26438513), [Arch Pathol Lab Med 2003;127:748](12741905), [Am J Surg Pathol 2008;32:1868](18813122), [Cureus 2021;13:e12850](33628700)"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-17",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#microscopichistologicimages405642",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Ryanne A. Brown, M.D., M.B.A.  \n\n[![dermal histiocytoid cells](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown01.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown01.jpg)\n\nDermal histiocytoid cells\n\n[![histiocytoid cells](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown02.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown02.jpg)\n\nHistiocytoid cells\n\n[![CD68](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown03.jpg)\n\nCD68\n\n[![CD1a](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown04.jpg)\n\nCD1a\n\n  \n\n[![S100](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown05.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown05.jpg)\n\nS100\n\n[![Langerin](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown06.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown06.jpg)\n\nLangerin\n\n[![BRAF V600E](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown07.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown07.jpg)\n\nBRAF V600E"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-18",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#positivestains405648",
    "clean_content": "Positive stains\n\n* Positive for [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html), [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html)* Variably express [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html), [CD45](https://www.pathologyoutlines.com/topic/cdmarkerscd45.html), [CD56](https://www.pathologyoutlines.com/topic/cdmarkerscd56.html), [lysozyme](https://www.pathologyoutlines.com/topic/stainslysozyme.html)* References: [Am J Dermatopathol 2018;40:736](29877893), [Blood 2015;126:2344](26438513), [Arch Pathol Lab Med 2003;127:748](12741905), [Am J Surg Pathol 2008;32:1868](18813122)"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-19",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#negativestains405649",
    "clean_content": "Negative stains\n\n* Negative for [langerin (CD207)](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)* Negative for histiocytic marker [CD163](https://www.pathologyoutlines.com/topic/cdmarkerscd163.html)* B cell and T cell markers, follicular dendritic cell markers ([CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html), [CD23](https://www.pathologyoutlines.com/topic/cdmarkerscd23.html) and [CD35](https://www.pathologyoutlines.com/topic/cdmarkerscd30to39.html#cd35)), [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html) and [MPO](https://www.pathologyoutlines.com/topic/stainsmyeloperoxidase.html)* References: [Am J Dermatopathol 2018;40:736](29877893), [Blood 2015;126:2344](26438513), [Arch Pathol Lab Med 2003;127:748](12741905), [Am J Surg Pathol 2008;32:1868](18813122)"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-20",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Flow cytometry description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#flowcytometrydescription405650",
    "clean_content": "Flow cytometry description\n\n* No known abnormalities in peripheral blood flow cytometry in true cutaneous indeterminate cell histiocytosis* For flow cytometry information for cases of chronic myelomonocytic leukemia with an indeterminate cell-like immunophenotype, please refer to [chronic myelomonocytic leukemia](https://www.pathologyoutlines.com/topic/myeloproliferativecmml.html)"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-21",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Electron microscopy description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#electronmicroscopydescription405652",
    "clean_content": "Electron microscopy description\n\n* Histiocytic cells show nuclear infoldings with peripheral villi ([Rare Tumors 2013;5:e13](23772299))* Lamellated dense bodies but no Birbeck granules ([Acta Derm Venereol 2002;82:288](12361135))"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-22",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Electron microscopy images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#electronmicroscopyimages405653",
    "clean_content": "Electron microscopy images\n\nContributed by Ryanne A. Brown, M.D., M.B.A.  \n\n[![No Birbeck granules](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown08.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesindeterminatecelltumorsbrown08.jpg)\n\nNo Birbeck granules"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-23",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#molecularcytogeneticsdescription405654",
    "clean_content": "Molecular / cytogenetics description\n\n* *ETV3::NCOA2* in a subset ([Blood 2015;126:2344](26438513), [BMJ Case Rep 2017;2017:bcr2017221538](29070620))* *BRAF* V600E in rare cases ([Ann Diagn Pathol 2015;19:113](25787243), [Virchows Arch 2017;471:467](28695297))* Can share clonal abnormality of associated lymphoma or leukemia ([Am J Surg Pathol 2008;32:1868](18813122))* *TP53* in 1 case ([Leukemia 2022;36:573](34611301))"
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-24",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#samplepathologyreport405657",
    "clean_content": "Sample pathology report\n\n* Skin, left arm, biopsy:\n  + Compatible with indeterminate cell histiocytosis (see comment)+ Comment: The presence of histiocytes that express CD1a without langerin is compatible with a diagnosis of indeterminate cell histiocytosis (ICH). The definitive etiology of ICH is not known. ICH may represent a distinct entity, as suggested by the detection of *ETV3::NCOA2* in a subset of cases or a variant of Langerhans cell histiocytosis (LCH) that has lost its Birbeck granules ([Blood 2015;126:2344](26438513)). Furthermore, chronic myelomonocytic leukemia (CMML) presenting with skin lesions rarely may mimic the immunohistochemical phenotype of ICH ([J Cutan Pathol 2017;44:1075](28885734)). If clinically indicated, correlation with genomic sequencing to assess for molecular aberrancies characteristic of ICH, LCH or CMML is recommended.+ Microscopic description: The histologic sections show skin with a nodular infiltrate of epithelioid cells with abundant eosinophilic cytoplasm, vesicular and variably reniform nuclei and prominent nucleoli present in sheets in the superficial and mid-dermis. On immunohistochemical staining, the lesional cells are positive for CD1a, S100 and CD68 and are negative for langerin, MPO and BRAF V600E."
  },
  {
    "id": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt-25",
    "source_document": "indeterminate-cell-histiocytosis--indeterminate-dendritic-cell-tumor_43236_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesindeterminatecelltumors.html#differentialdiagnosis405658",
    "clean_content": "Differential diagnosis\n\n* [Langerhans cell histiocytosis](https://www.pathologyoutlines.com/topic/lymphnodesLCH.html):\n  + [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)+, [langerin (CD207)](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)+ (100%), [S100](https://www.pathologyoutlines.com/topic/stainss100.html)+, [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html)+, [BRAF VE1](https://www.pathologyoutlines.com/topic/stainsbraf.html) (~50%)* [Juvenile xanthogranuloma](https://www.pathologyoutlines.com/topic/skintumornonmelanocyticjuvenilexantho.html):\n    + [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)-, [langerin (CD207)](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)-, [S100](https://www.pathologyoutlines.com/topic/stainss100.html) variable, [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html)+* [Multicentric reticulohistiocytosis](https://www.pathologyoutlines.com/topic/skintumormultireticulo.html):\n      + [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)-, [langerin (CD207)](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)-, [S100](https://www.pathologyoutlines.com/topic/stainss100.html) variable, [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html)+* [Interdigitating dendritic cell sarcomas](https://www.pathologyoutlines.com/topic/lymphnodesinterdigitatingreticulum.html):\n        + [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)-, [langerin (CD207)](https://www.pathologyoutlines.com/topic/cdmarkerscd200.html#cd207)-, [S100](https://www.pathologyoutlines.com/topic/stainss100.html)+, [SOX10](https://www.pathologyoutlines.com/topic/stainssox10.html)+* [Histiocytic sarcoma](https://www.pathologyoutlines.com/topic/lymphnodeshistiocyticsarcoma.html):\n          + Significant cytologic atypia, [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html)-* [Chronic myelomonocytic leukemia](https://www.pathologyoutlines.com/topic/myeloproliferativecmml.html) secondarily involving the skin:\n            + Can have identical morphologic and immunohistochemical findings, correlate with molecular studies ([J Cutan Pathol 2017;44:1075](28885734))* **Reactive indeterminate cell infiltrates**:\n              + [Tick bite](https://www.pathologyoutlines.com/topic/parasitologytickhyalomma.html) ([Pediatr Dermatol 2017;34:e347](28940363))+ [Scabies](https://www.pathologyoutlines.com/topic/skinnontumorscabies.html) ([J Dermatol 2000;27:181](10774146))"
  }
]